BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 1, 2013

View Archived Issues

VaxLogic licenses QS-21 adjuvant from Agenus

Read More

Scientists create zebrafish model of hyperammonemia

Read More

Endece Neural receives funding to advance myelin repair compound

Read More

Inotek Pharmaceuticals raises funds to support development of trabodenoson

Read More

Novel genetic susceptibility loci identified in patients with anorexia nervosa

Read More

Eteplirsen shows continued stability on walking test in DMD study

Read More

Phase II clinical comparison of drug delivery systems in patients with type 2 diabetes

Read More

Etubics receives SBIR grant for breast cancer immunotherapeutic

Read More

Evotec achieves another milestone in collaboration with Boehringer Ingelheim

Read More

Kissei and JCR Pharmaceuticals collaborate on darbepoetin alfa biosimilar

Read More

[68Ga]Pentixafor allows PET imaging of CXCR4 expression in humans

Read More

Results of phase III trial demonstrate improvements in PFS and PSA responses with ipilimumab

Read More

FDA grants orphan drug designation to OMS-824 for Huntington's disease

Read More

Gliknik enters agreement with Pfizer for autoimmune disease drug candidate

Read More

AcelRx Pharmaceuticals submits Zalviso NDA

Read More

Lithera reports data from the phase IIb RESET trial for LIPO-202

Read More

Astellas Pharma reports topline phase III data for isavuconazole

Read More

FDA approves Cimzia for treatment of active psoriatic arthritis

Read More

New furin inhibitors disclosed by U.S. researchers

Read More

Glucox Biotech patents novel NADPH oxidase inhibitors

Read More

Stapled TRF2 peptides allow exploration of RAP1-TRF2 interaction

Read More

Bracco Imaging presents new agents for magnetic resonance imaging

Read More

Lupin discloses novel MEK/ERK inhibitors

Read More

FDA grants orphan drug status to several drugs for cancer treatment

Read More

FDA approves vortioxetine for major depressive disorder

Read More

Vertex files sNDA for Kalydeco

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 8, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing